Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guérin (BCG) among HIV- positive children and adults in Zambia
- PMID: 11192868
- DOI: 10.1097/00002030-200101050-00009
Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guérin (BCG) among HIV- positive children and adults in Zambia
Abstract
Background: Among adults with advanced HIV infection in developing countries, bacteremia due to Mycobacterium tuberculosis (MTB) is common and bacteremia due to M. bovis (bacille Calmette-Guérin; BCG) is rare. Comparable data are not available for children with HIV.
Objective: To compare the prevalence of bacteremia due to M. tuberculosis or M. bovis BCG in hospitalized children and adults with HIV infection in a developing country with a high prevalence of tuberculosis and HIV and > 95% BCG immunization coverage.
Design: Descriptive cross-sectional study.
Methods: Prospectively hospitalized patients in Lusaka, Zambia who were suspected to have HIV infection underwent phlebotomy for HIV ELISA, HIV viral load, and lysis-centrifugation blood culture for mycobacteria. Histories were obtained and patients were examined for BCG scars. Mycobacterial isolates were identified using DNA probes for MTB complex (MTBC), multiplex PCR and IS6110 typing.
Results: The median age of 387 HIV-positive children was 15 months; 98% were BCG immunized. The median age of 344 HIV-positive adults was 32 years; 44% were BCG immunized. Blood cultures were positive for mycobacteria in six children (2%) and 38 adults(11%) (P < 0.001). The six pediatric isolates included five MTBC (40% clustered) and one BCG. The 38 adult isolates included 36 MTBC (16% clustered) and two M. avium complex.
Conclusion: Bacteremia due to MTB is less common among children than adults with advanced HIV infection in Zambia. Bacteremia due to M. bovis BCG is rare even among children with recent BCG immunization and symptomatic HIV infection.
Similar articles
-
The risks and benefits of childhood bacille Calmette-Guérin immunization among adults with AIDS. International MAC study groups.AIDS. 1997 Apr;11(5):669-72. doi: 10.1097/00002030-199705000-00015. AIDS. 1997. PMID: 9108949
-
Detection of bloodstream pathogens in a bacille Calmette-Guérin (BCG)-vaccinated pediatric population in Malawi: a pilot study.Clin Microbiol Infect. 2003 Mar;9(3):234-8. doi: 10.1046/j.1469-0691.2003.00517.x. Clin Microbiol Infect. 2003. PMID: 12667257
-
Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.Clin Infect Dis. 2003 Nov 1;37(9):1226-33. doi: 10.1086/378298. Epub 2003 Oct 6. Clin Infect Dis. 2003. PMID: 14557968
-
Use of the bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine.Am J Med Sci. 1997 Jun;313(6):372-6. doi: 10.1097/00000441-199706000-00010. Am J Med Sci. 1997. PMID: 9186153 Review.
-
[HIV-infection, AIDS and BCG vaccination].Kekkaku. 1993 Jun;68(6):435-44. Kekkaku. 1993. PMID: 8341039 Review. Japanese.
Cited by
-
Single nucleotide polymorphisms in the Mycobacterium bovis genome resolve phylogenetic relationships.J Clin Microbiol. 2012 Dec;50(12):3853-61. doi: 10.1128/JCM.01499-12. Epub 2012 Sep 19. J Clin Microbiol. 2012. PMID: 22993186 Free PMC article.
-
Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection.Clin Infect Dis. 2005 Oct 1;41(7):1049-52. doi: 10.1086/433177. Epub 2005 Aug 30. Clin Infect Dis. 2005. PMID: 16142674 Free PMC article.
-
Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.Vaccine. 2016 Jun 17;34(29):3342-9. doi: 10.1016/j.vaccine.2016.05.018. Epub 2016 May 16. Vaccine. 2016. PMID: 27195758 Free PMC article. Review.
-
Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.Pediatr Infect Dis J. 2013 Oct;32(10):1089-95. doi: 10.1097/INF.0b013e31829ee893. Pediatr Infect Dis J. 2013. PMID: 24067552 Free PMC article.
-
Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.AIDS. 2010 Mar 13;24(5):675-85. doi: 10.1097/QAD.0b013e3283350f1b. AIDS. 2010. PMID: 20118767 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical